
why choose our products
Frozen blood clam meat, known commercially as concha negra or blood cockle, has emerged as a notable commodity in global seafood trade. However, the 2025–2026 hepatitis A outbreak linked to imported product exposed critical compliance gaps that are reshaping the import landscape for this species.
Product Overview and Trade Patterns
Blood clams (scientific name Tegillarca granosa, also classified as Anadara granosa) are bivalve mollusks distinguished by their hemoglobin-rich red flesh, an adaptation allowing survival in low-oxygen muddy environments . Major suppliers include China, Vietnam, Indonesia, and Malaysia, with China accounting for approximately 40% of global clam exports .
Frozen blood clam meat is typically processed using IQF (Individually Quick Frozen) technology, extending shelf life to 24 months at -18°C. Chinese exporters offer specifications ranging from 200–300 to 500–1000 pieces per kilogram, with FOB prices around USD 2,500–3,000 per metric ton . Key markets include Australia, the Middle East, and North America.
The Ecuador Hepatitis A Outbreak: A Compliance Case Study
The most significant recent development in frozen blood clam trade was a hepatitis A outbreak traced to La Serranita brand concha negra imported from Ecuador. Illness onset dates ranged from July 2025 to May 2026, with 30 confirmed cases across Minnesota, New York, and Pennsylvania; 83% of patients required hospitalization . The FDA issued a public alert in April 2026 .
The core regulatory failure was straightforward: Ecuador is not among countries whose shellfish shippers are certified under the U.S. National Shellfish Sanitation Program. The FDA's Interstate Certified Shellfish Shippers List recognizes only shippers certified by the United States, Canada, Korea, Mexico, and New Zealand-governments holding formal shellfish sanitation agreements with the FDA . The implicated product entered the market outside this framework.
Crucially, freezing does not eliminate hepatitis A risk. The virus survives freezing and retains infectivity for the product's full shelf life, which can extend to 24 months under proper cold-chain conditions . Unlike bacterial pathogens that may decline over time, hepatitis A is persistent and heat-resistant, surviving brief cooking temperatures. This means a contaminated shipment remains hazardous long after leaving the port of origin.
Implications for Importers and Distributors
The outbreak delivered a blunt lesson: origin certification is a core procurement specification, not a back-office formality. For importers, the practical takeaways are:
Verify certification directly against official shippers lists before contracting, rather than relying on a seller's verbal assurances of compliance .
Fix the Latin species name on purchase orders to prevent substitution between related ark shell species .
Require health certificates, certificates of analysis, and origin documentation with each shipment .
Treat any shipment from a non-certified country as ineligible, regardless of documentation presented .
The commercial fallout has been instructive. Buyers who sourced on price alone discovered that savings from uncertified suppliers can be erased many times over by recall costs, legal liability, and reputational damage . Retail and foodservice customers increasingly demand full traceability from harvest area to point of sale.
Market Outlook
For exporters in certified countries, stricter enforcement represents an opportunity: higher barriers to entry for non-compliant competitors reward suppliers with verifiable compliance records . For exporters in non-certified countries, the path forward lies in pursuing formal recognition through bilateral shellfish sanitation agreements-a process typically taking years and requiring substantial investment in monitoring, harvesting controls, and laboratory capacity .
As frozen blood clam meat continues to move through Asian and North American supply chains, the distinction between a legally importable product and an illegally sourced one can determine not only customs clearance but public-health liability. Those who treat origin certification as a core procurement specification will be better positioned to weather both regulatory scrutiny and the market's growing demand for verifiable food safety .
